Skip to main content
Home

Main navigation

  • Home
  • News
  • About HIV
  • About us
Search
Donate
Donate now

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you.

I am a UK taxpayer and I understand that if I pay less Income and /or Capital Gains Tax than the amount of Gift Aid claimed on all my donations in the relevant tax year, it is my responsibility to pay any difference.

In our 35th year we’re asking people to donate £35 – that’s just £1 for every year we’ve been providing life-changing information. Any donation you make helps us continue our work towards a world where HIV is no longer a threat to health or happiness.

  • £5 allows us to reach millions of people globally with accurate and reliable resources about HIV prevention and treatment.
  • £10 helps us produce news and bulletins on the latest developments in HIV for healthcare staff around the world.
  • £35 means we can empower more people living with HIV to challenge stigma with our information workshops, videos and broadcasts.
Conferences

IDWeek 2015

The IDWeek 2015 conference was held in San Diego, USA, 7-11 October 2015.
Hepatitis C treatment

People with HIV and HCV co-infection achieve high HCV cure rates with grazoprevir/elbasvir

15 November 2015
The search for a cure

Post-treatment control of HIV appears rare, biomarkers may help predict viral rebound

4 November 2015
HIV treatment

One third of people with HIV in US study are not virally suppressed on antiretroviral therapy

21 October 2015
Hepatitis & HIV

Sofosbuvir + daclatasvir demonstrates high cure rates for people with HIV and HCV co-infection

21 October 2015
Harm reduction

Emergency needle exchange in Indiana reduces HIV and HCV risk for people who inject drugs

20 October 2015
New & experimental HIV treatments

Studies continue to support tenofovir alafenamide combination pill as it nears US approval

19 October 2015
Hepatitis C symptoms & diagnosis

Hepatitis C-related mortality continues to increase in the US

16 October 2015
New & experimental HIV treatments

HIV attachment inhibitor BMS-663068 matches atazanavir in phase 2b study

14 October 2015
Access to healthcare

Affordable Care Act coverage improves chances of viral suppression for Americans with HIV

12 October 2015
Sign up for our email bulletins.
Sign up

Editors’ picks from other sources

More editors' picks

About us

NAM is a charity based in the United Kingdom. We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital in the fight against HIV & AIDS.

Our information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.

Read more about us

Connect with us

  • Twitter
  • Facebook
  • YouTube
  • Instagram
Subscribe to emails & newsfeeds

Login to our clinic portal
Donate

Visit NAM’s other websites: clinic.nam.org.uk | infohep.org | prepineurope.org | about-hiv.info | pro-vich.info | hiv-lens.org

© NAM Publications 2023, all rights reserved. NAM is not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Footer menu

Show — Footer menu Hide — Footer menu
  • Contact
  • Jobs
  • Terms of Use
  • Accessibility
  • Privacy Policy
  • Cookies
  • Manage cookies